Valosomnin (Capsules) Instructions for Use
Marketing Authorization Holder
Moscow Pharmaceutical Factory CJS (Russia)
ATC Code
N05CM (Other hypnotic and sedative drugs)
Active Substances
Extractum rhizomatum cum radicibus Valerianae officinalis (Grouping name)
Melissa (DAB German Pharmacopoeia)
Peppermint (USAN adopted for use in the USA)
Dosage Form
| Valosomnin | Capsules: 20, 40, 60, or 100 pcs. |
Dosage Form, Packaging, and Composition
Capsules hard gelatin, size No. 2, body and cap of reddish-brown color; the capsule contents are a powder or compressed mass of brown color with inclusions of darker and lighter shades, with a characteristic odor.
| 1 capsule | |
| Valerian officinalis rhizomes with roots dry extract ((4-7):1) | 125 mg, |
| Equivalent to native extract | 87.5 mg |
| Melissa officinalis leaf dry extract ((3-6):1) | 25 mg, |
| Equivalent to native extract | 17.5 mg |
| Peppermint leaves dry extract ((3-6):1) | 25 mg, |
| Equivalent to native extract | 17.5 mg |
Excipients : magnesium oxide – 6 mg, lactose monohydrate – 85.5 mg, talc – 8.1 mg, colloidal silicon dioxide – 3.2 mg, magnesium stearate – 2.2 mg.
Composition of the hard gelatin capsule titanium dioxide (E171) – 1%, iron oxide red dye (E172) – 0.85%, iron oxide yellow dye (E172) – 0.25%, gelatin – up to 100%.
10 pcs. – blister packs (2) – cardboard packs.
10 pcs. – blister packs (4) – cardboard packs.
10 pcs. – blister packs (6) – cardboard packs.
100 pcs. – polymer jars (1) – cardboard packs.
Clinical-Pharmacological Group
Sedative herbal preparation
Pharmacotherapeutic Group
Herbal sedative
Pharmacological Action
A combined herbal medicine with sedative and antispasmodic effects.
Extract of valerian rhizomes with roots has a sedative effect.
Melissa leaf extract has sedative and antispasmodic effects.
Peppermint leaf extract has an antispasmodic and moderate sedative effect.
Indications
Increased nervous excitability; insomnia; irritability.
ICD codes
| ICD-10 code | Indication |
| F48.0 | Neurasthenia |
| F48.9 | Unspecified neurotic disorder |
| F51.0 | Nonorganic insomnia |
| R45.0 | Nervousness |
| R45.4 | Irritability and anger |
| ICD-11 code | Indication |
| 6A8Z | Affective disorders, unspecified |
| 6B6Z | Dissociative disorders, unspecified |
| 7A00 | Chronic insomnia |
| 7A01 | Acute insomnia |
| 7A0Z | Insomnia disorders, unspecified |
| MB24.3 | Anxiety |
| MB24.C | Irritability |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally. Take a single dose of 1-2 capsules two to three times daily.
Ingest the last dose 30-60 minutes before bedtime to facilitate sleep onset.
Do not exceed the maximum daily dose.
Swallow the capsules whole with a sufficient amount of water; do not chew.
Treatment duration is typically 2 to 4 weeks.
Do not use the drug continuously for more than 1.5 to 2 months without consulting a physician.
Discontinuation can be abrupt; no withdrawal syndrome develops upon cessation of therapy.
If no therapeutic effect is observed after a full treatment course, or if symptoms worsen, seek medical advice.
Exercise caution when engaging in activities requiring increased concentration and psychomotor speed, such as driving or operating machinery.
Adverse Reactions
Allergic reactions possible – hyperemia, skin rash, peripheral edema, allergic dermatitis), bronchospasm.
From the digestive system with prolonged use, constipation is possible.
Contraindications
Arterial hypotension; cholangitis, cholelithiasis and other diseases of the biliary tract; pregnancy, breastfeeding period; children under 12 years of age; hypersensitivity to the components of the drug.
With caution GERD.
Use in Pregnancy and Lactation
Use during pregnancy and lactation (breastfeeding) is contraindicated.
Pediatric Use
The use of the drug in children under 12 years of age is contraindicated.
Special Precautions
In patients with GERD, symptoms may worsen.
If symptoms persist or worsen during the use of the drug, the patient should consult a doctor.
The drug should not be used continuously for more than 1.5-2 months.
Effect on the ability to drive vehicles and machinery
During treatment, patients should exercise caution when engaging in potentially hazardous activities that require increased concentration and speed of psychomotor reactions (driving vehicles, working with moving machinery, work of a dispatcher, operator).
Drug Interactions
With simultaneous use of the drug with other drugs that depress the central nervous system (including hypnotics, centrally acting antihypertensive drugs, analgesics), an enhancement of the effect on the central nervous system is possible (dose adjustment may be required).
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer